Analysis of 97 Adverse Drug Reaction/Event Cases Induced by Traditional Chinese Medicine Injections

Abstract

Abstract: Objective Analyzed serious adverse drug reaction/event(ADR/ADE) of traditional Chinese medicine(TCM)injections from 97 ADR/ADE reports analysis to provide the references information in clinical application. Methods 97 ADR/ADE reports of TCM injections collected by Jiangyin People's Hospital from January 2007 to December 2009 were analyzed using retrospective study method. Results Higher ADR/ADE occurrence is observed in old people than other age groups in the study．The majority of reported ADR/ADE were skin and body as a whole-general disorders. Conclusion ADR/ADE caused by TCM injections can not be ignored, so ADR/ADE should be intensively monitored and treated timely in clinical treatment．

Key words: Traditional Chinese Medicine injections, adverse drug reaction/event, analysis

CLC Number:

R286
R994.11

ZHANG Ying. Analysis of 97 Adverse Drug Reaction/Event Cases Induced by Traditional Chinese Medicine Injections[J]. Chinese Journal of Pharmacovigilance, 2011, 8(8): 498-500.

[1]	JIA Yinyin, ZHANG Caishu, ZHOU Ying, LIU Li, GENG Ying, WEI Ningyi, NIU Sijing, CHEN Hua, XU Hui. Evaluation methods for aerodynamic particle size distribution of fine particles in inhaled products [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 141-146.
[2]	FAN Kaikai, WANG Cong, LIU Hongfeng, WANG Xiyong. Effects of clinical pharmacist interventions on usage of alanyl-glutamine injections in a hospital [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 181-184.
[3]	GAO Yunjuan, ZHAO Xu, BAI Tiankai, BAI Zhaofang, WANG Jiabo, SONG Haibo, XIAO Xiaohe. Discovery and identification strategy for drug safety risks based on big data monitoring of adverse reactions [J]. Chinese Journal of Pharmacovigilance, 2024, 21(1): 1-5.
[4]	YUAN Sisi, WANG Guangyan, LI Yifan, LI Ruilian, DU Boran, FENG Xin. Safety-related risk factors in clinical management of narcotics and psychotropic substances via failure mode and effect analysis [J]. Chinese Journal of Pharmacovigilance, 2023, 20(9): 1027-1030.
[5]	LIU Qian, HU Jing, LI Bo, YANG Xiaojing. Jinghuaweikang capsules combined with quadruple therapy in the treatment of Helicobacter pylori associated gastritis: a systematic evaluation and meta-analysis [J]. Chinese Journal of Pharmacovigilance, 2023, 20(9): 1039-1045.
[6]	ZHANG Xialan, YUAN Jing, WU Bin, QIN Yuanyuan. Medications of apatinib mesylate in patients with malignant tumors [J]. Chinese Journal of Pharmacovigilance, 2023, 20(8): 927-932.
[7]	CHANG Yongzhuo, LI Ji, ZHANG Xiaoyan, ZHOU Chaofan. One case of abnormal uterine bleeding caused by Baofukang suppository [J]. Chinese Journal of Pharmacovigilance, 2023, 20(8): 935-938.
[8]	MENG Kangkang, LIU Saiyue. After-marketing safety of coenzyme Q10 for injection [J]. Chinese Journal of Pharmacovigilance, 2023, 20(7): 795-798.
[9]	ZHANG Lei, LYU Jian, XIE Yanming. Efficacy and safety of Houpupaiqi Mixture in the treatment of postoperative lieus: a Meta-analysis [J]. Chinese Journal of Pharmacovigilance, 2023, 20(7): 799-806.
[10]	LIU Jingjing, DAI Zhong, YANG Jianbo, WANG Ying, XU Beilei, LIU Yue, WANG Qi, MA Shuangcheng. Spectrum-fect relationship of Ginseng Radix et Rhizoma Rubra and Polygonum Multiflorum Radix Preparata medicinal pair in protection of nerve cells [J]. Chinese Journal of Pharmacovigilance, 2023, 20(6): 623-628.
[11]	CHEN Xiao, GUO Xiaojing, XU Jinfang, WEI Lianhui, CHEN Chenxin, LIANG Jizhou, ZHENG Yi, YE Xiaofei. Machine learning method in the detection of adverse drug reaction signals of brigatinib based on FAERS database [J]. Chinese Journal of Pharmacovigilance, 2023, 20(6): 639-645.
[12]	ZHAO Xuan, GUO Jing, CHEN Ning, MEI Long, ZHENG Tingting, ZHANG Lifang, ZHANG Wei. Discuss the safety management of medical toxic drugs in medical institutions [J]. Chinese Journal of Pharmacovigilance, 2023, 20(6): 705-708.
[13]	LIU Baosheng, WANG Guanjie, WANG Zhenhua, LIU Lihong, ZHU Yan, ZHOU Xiuli. One case of acute liver injury caused by tripterygium glycosides tablets [J]. Chinese Journal of Pharmacovigilance, 2023, 20(5): 511-513.
[14]	CHENG Fengjingming, LYU Jian, XIE Yanming. Efficacy and safety of compound salvia miltiorrhiza spray/aerosol for angina pectoris due to coronary artery disease: a Meta analysis [J]. Chinese Journal of Pharmacovigilance, 2023, 20(5): 536-543.
[15]	WANG Guohua, LI Xiaolei, LIU Xiping, DONG Yizhi, ZANG Chen, XU Hong, TIAN Jixiang, ZHAO Jing. Aerosol inhalation of Tanreqing injection in the treatment of chronic obstructive pulmonary disease: a Meta-analysis [J]. Chinese Journal of Pharmacovigilance, 2023, 20(5): 544-552.

Analysis of 97 Adverse Drug Reaction/Event Cases Induced by Traditional Chinese Medicine Injections

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics